|
MedSci - Senior Associate Scientist - NB50304284 - Thousand Oaks, CA
| Details |
Country: USA
Location: California-Ventura County Thousand Oaks, CA 91319
Total applied: 40
|
|
MedSci - Senior Associate Scientist - NB50304284 - Thousand Oaks, CA
Amgen (NASDAQ:AMGN), a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance science to serve patients.The candidate will be responsible for development and validation of assays to support analyses in clinical studies. This may include activities ranging from biomarker discovery using human tissues, to assay qualification and execution at GLP-like levels of compliance.BS in biological sciences with at least 3 years experience in the biopharmaceutical or contract research industries specifically in biomarker assay development. Experience with immunoassays, cytometry based assays, and or lab automation are required. Experience with the performance of these assays using clinical samples is considered desirable and experience with assay qualification/validation would be beneficial. Amgen is the leading human therapeutics company in the biotechnology industry. Our mission is to serve patients. We foster a culture of innovation, using our expertise in advanced science and technology to find new and better medicines to fight serious illness. For more information about Amgen, our visionary science, and our powerful medicines, visit: www.amgen.com Company: Amgen Inc Location: Thousand Oaks, CA 91319 Job Category: Biotech/R&D/Science Reference Code: 50304284
|
| Related jobs |
|
|
Director Regulatory Affairs, NB50272115 - Thousand Oaks, CA
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize ...
|
|
|
Sr. Associate Scientist - PKDM - NB50223923 - Thousand Oaks, CA
Amgen (NASDAQ:AMGN), a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight ...
|
|
|
SIEBEL DEVELOPER
Major corporation has a great contract opportunity available for an experienced:
SIEBEL DEVELOPER
Siebel 8 configuration/development, business services, eScript, ...
|
|
|
BUSINESS SYSTEMS ANALYSTS
Major corporation has a great consulting opportunity for two
Business Systems Analysts POSITION #1: Job Summary:
The primary responsibility of the IS B...
|
|
|
Business Systems Analyst
Location: Thousand Oaks, CA 91319Your location:home   »  find a job   »  advanced search   »  job description Apply Online Send ...
|
|
|
Scientist- NB50310402 - Thousand Oaks
Amgen (NASDAQ:AMGN), a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight ...
|
|
|
Manufacturing Chemist
Manufacturing Chemist
About the job
Agilent’s Life Sciences Solutions Unit (LSSU) is creating the tools and technologies that are changing ...
|
|
|
Respiratory - Manager Operational Excellence
Manager OpExNellcor Puritan Bennett, is now the Respiratory and Monitoring Solutions (RMS) business unit of Covidien, formerly Tyco Healthcare. RMS systems are used to ...
|
|
|
Supplier Quality Engineer - NPD (EE) (EBD)
Manufacturing/Production/Operations    Total Work Experience: ...
|
|
|
District Sales Mgr - Fort Collins; CO
Boulder/Fort Collins, CO Sales/Retail/Business Development Job SummaryExternal Summary of Primary Responsibilities: Provides inspirational leadership and ...
|
|
| Related press releases |
Courageous reform
There can be little doubt we are making progress when it comes to improving further education. More young people and adults than ever are gaining good qualifications ever...
|
|
Half of MG Rover workers want to return
Almost a year after the collapse of MG Rover, many former workers are paid less and wish they still worked for the firm, according to a report released today.
Of the nea...
|
|
Making ends meet
Earning some dosh to get through uni might seem unavoidable, but don't lose sight of the reason you are there: to get a degree. Earning shouldn't mean missing vital lectu...
|
|
|
|
The earth man cometh
I am merely the conduit,' says Patrick Holden, director of the Soil Association, when I ask him to sum up his achievement after 10 years in the job. 'The great thinkers, ...
|
|
Battle at the coalface
In his television review Rupert Smith described the NUM miners leader Arthur Scargill as "a ghastly little man who needed to be trodden on" (G2, March 23). I suppose he w...
|
|
Hutton eases small firms' pension fears
The government will not force employers to contribute to workers' pensions without making efforts to minimise the impact on firms, the work and pensions secretary, John H...
|
|
NHS hospital redundancies gather pace
A wave of redundancies across the NHS in England gathered force yesterday when a London teaching hospital announced that nearly 500 posts will be axed in an attempt to di...
|
|
Union warning over 'raw' stalls handlers
The Transport and General Workers Union (T&G) yesterday launched a fierce attack on the overall standard of the stalls handlers likely to be working at British racecourse...
|
|
Minimum wage to rise to £5.35
The minimum wage will rise by 6% in October to £5.35, the government confirmed yesterday, but it cautioned that the days of big, inflation-beating rises may be over...
|
|
|
|
Biotechnology & Pharmaceuticals